Intellectus Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Intellectus Partners’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Buy	15,686 +3,684	+31%	+$548K	0.43%	55
2026 Q1	$1.76M	Buy	12,002 +2,227	+23%	+$344K	0.36%	74
2025 Q4	$1.51M	Buy	9,775 +3,284	+51%	+$492K	0.29%	87
2025 Q3	$903K	Buy	6,491 +575	+10%	+$77.8K	0.18%	139
2025 Q2	$797K	Buy	5,916 +1,495	+34%	+$202K	0.17%	151
2025 Q1	$645K	Sell	4,421 -350	-7%	-$50.8K	0.16%	160
2024 Q4	$656K	Buy	4,771 +51	+1%	+$7.46K	0.15%	172
2024 Q3	$727K	Sell	4,720 -140	-3%	-$21.2K	0.19%	160
2024 Q2	$708K	Buy	4,860 +57	+1%	+$8.18K	0.19%	144
2024 Q1	$710K	Buy	4,803 +253	+6%	+$36.3K	0.19%	151
2023 Q4	$621K	Buy	4,550 +3	+0.1%	+$390	0.18%	152
2023 Q3	$585K	Buy	4,547 +4	+0.1%	+$531	0.19%	153
2023 Q2	$603K	Buy	4,543 +3	+0.1%	+$395	0.18%	161
2023 Q1	$588K	Sell	4,540 -139	-3%	-$18.2K	0.19%	153
2022 Q4	$636K	Buy	4,679 +3	+0.1%	+$398	0.22%	140
2022 Q3	$566K	Sell	4,676 -342	-7%	-$44.1K	0.2%	140
2022 Q2	$644K	Sell	5,018 -147	-3%	-$19.3K	0.22%	130
2022 Q1	$708K	Sell	5,165 -172	-3%	-$22.8K	0.21%	124
2021 Q4	$752K	Sell	5,337 -266	-5%	-$35.3K	0.19%	142
2021 Q3	$713K	Sell	5,603 -162	-3%	-$21.4K	0.17%	148
2021 Q2	$726K	Sell	5,765 -1,055	-15%	-$129K	0.16%	160
2021 Q1	$796K	Sell	6,820 -578	-8%	-$66.7K	0.22%	135
2020 Q4	$839K	Sell	7,398 -798	-10%	-$87.1K	0.25%	124
2020 Q3	$865K	Sell	8,196 -15,873	-66%	-$1.67M	0.33%	97
2020 Q2	$2.41M	Buy	24,069 +182	+0.8%	+$18K	0.93%	25
2020 Q1	$2.12M	Buy	23,887 +2,543	+12%	+$247K	1.01%	24
2019 Q4	$2.21M	Sell	21,344 -308	-1%	-$29.6K	0.9%	26
2019 Q3	$1.95M	Sell	21,652 -52	-0.2%	-$4.75K	0.86%	28
2019 Q2	$2.01M	Buy	21,704 +178	+0.8%	+$16K	0.87%	26
2019 Q1	$1.98M	Buy	+21,526	New	+$1.94M	0.85%	25
2018 Q4	–	Sell	-19,135	Closed	-$1.82M	–	535
2018 Q3	$1.82M	Buy	19,135 +3,025	+19%	+$273K	0.64%	33
2018 Q2	$1.34M	Buy	16,110 +2,289	+17%	+$190K	0.49%	49
2018 Q1	$1.13M	Buy	13,821 +6,287	+83%	+$536K	0.39%	65
2017 Q4	$623K	Buy	7,534 +3,572	+90%	+$295K	0.23%	113
2017 Q3	$324K	Buy	3,962 +846	+27%	+$67.9K	0.13%	168
2017 Q2	$247K	Buy	+3,116	New	+$237K	0.11%	178

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Intellectus Partners's XLV Position: Q2 2026 in Review

Intellectus Partners increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 31% in Q2 2026, buying an estimated $548K and bringing the position to 15,686 shares worth $2.49M. The position accounts for 0.43% of the portfolio, ranked #55.

Intellectus Partners first reported a position in XLV in Q2 2017 and has held it in 36 quarters since. 1,853 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Intellectus Partners held 15,686 shares of State Street Health Care Select Sector SPDR ETF worth $2.49M as of Q2 2026.
Intellectus Partners bought 3,684 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $548K.
State Street Health Care Select Sector SPDR ETF made up 0.43% of Intellectus Partners's portfolio in Q2 2026, its #55 holding.
Intellectus Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2017 and has held it in 36 quarters since.
1,853 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.